Skip to main content

$3.18 0.09 (2.91%)

High

$3.18

Low

$3.12

Trades

1,177

Turnover

$3,954,133

Volume

1,248,327
30 June 2023 at 4:12pm
Register to track HLS and receive email alerts.

ASX Announcements (7d)

-

Twitter Mentions (7d)

0+

AFR Articles (7d)

1

News Articles (7d)

1+
Subject
HLS Ann: Change in substantial holding

HLS Ann: Change of Director's Interest Notice

HLS Ann: Notification regarding unquoted securities - HLS

HLS Ann: Directors' Statement re Takeover

HLS Ann: ACL: Response to Healius' Target's Statement

HLS Ann: ACL: Second Supplementary Bidder's Statement

HLS Ann: Appointment of Group Executive, Healius Pathology

HLS Ann: ACL: Takeover offer - receipt of Target's Statement

HLS Ann: Lodgement of Target's Statement

HLS Ann: Notification of cessation of securities - HLS

HLS Ann: Update on DH sale, debt covenant waiver and consensus

HLS Ann: Update on ASX waiver for issue of performance rights

HLS Ann: Notification of cessation of securities - HLS

HLS Ann: Notification of cessation of securities - HLS

HLS Ann: ACL:Completion of dispatch of replacement bidder's statement

HLS Ann: ACL: Commencement of dispatch of replacement bidder's stmt

HLS Article: ACL, Healius saga enlivens fine art of M&A trade craft

HLS Ann: Electronic Delivery of Target's Statement

HLS Article: Takeovers Panel declines to adjudicate on hostile Healius takeover

HLS Ann: TOV: HLS Panel Declines to Conduct Proceedings

HLS Ann: ACL: ASX announcement - Replacement Bidder's Statement

HLS Ann: ACL: Replacement Bidder's Statement

HLS Ann: ACL: First Supplementary Bidder's Statement

HLS Article: Crescent Capital locks in $1b for seventh fund, CEFC cuts a cheque

HLS Article: ACL shareholder likes Healius takeover thinking, increases stake

HLS Article: Healius asks takeovers tsar to curb hostile suitor

HLS Ann: TOV: HLS Panel Receives Application

HLS Ann: Company Secretary Appointment/Resignation

HLS Article: Healius slings ACL bid to Takeovers Panel

HLS Ann: Directors' Statement re Takeover

HLS Article: Wylie’s Tanarra Capital spoils ACL’s Healius buyout hopes

HLS Article: Gresham gets a bait on Healius, rivals scramble for mandates

HLS Article: ACL unlikely to succeed with Healius offer, analysts say

HLS Ann: Appointment of Charlie Taylor as a Non-executive Director

HLS Ann: Initial Directors Interest Notice

HLS Ann: Company Secretary Appointment/Resignation

HLS Article: ASX sinks 1.4pc to four-month low; gold miners rocket

HLS Article: Australian Clinical Labs makes play for Healius

HLS Article: Opportunistic Clinical Labs tries to pull off dream deal with Healius

HLS Ann: Becoming a substantial holder from ACL

HLS Ann: ACL: People to whom information is to be sent

HLS Article: ‘A few poorly managed banks’ to blame, says RBA’s Kent

HLS Ann: Off-market takeover bid from ACL

HLS Article: Large portion of UBS cost-cutting will be reducing staff

HLS Ann: ACL: Investor Webinar - Takeover Offer for Healius

HLS Ann: ACL: Investor Presentation - Takeover Offer for Healius

HLS Ann: ACL: Bidder's Statement in Takeover Offer for Healius

HLS Ann: ACL: Takeover Offer for Healius Limited

HLS Ann: Appendix 3Y Change of Director's Interest Notice

HLS Ann: Appendix 3Y Change of Director's Interest Notice

Register to track HLS and receive email alerts.

Similar Companies

AHX
BD1
CAJ
HLA
IDX
RHY
SHL
SLA
TTB